Clinical Trial Update: Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain [Phase 1]

View source ↗

Summary

This entry describes a Phase 1 clinical trial of topotecan in patients with recurrent, progressive, or refractory cancer that has metastasized to the meninges (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Leptomeningeal Carcinomatosis

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: NYU Langone Health | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED